Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial
经导管主动脉瓣置换术(TAVR)后,采用肝素或比伐卢定作为围手术期抗凝治疗的伴或不伴外周动脉疾病患者的临床结局:BRAVO-3随机试验的结果
期刊:Catheterization and Cardiovascular Interventions
影响因子:1.9
doi:10.1002/ccd.28642
Zilberszac, Robert; Chandiramani, Rishi; Hengstenberg, Christian; Sartori, Samantha; Cao, Davide; Chandrasekhar, Jaya; Schafer, Ulrich; Tchetche, Didier; Violini, Roberto; Jeger, Raban; Van Belle, Eric; Boekstegers, Peter; Hambrecht, Rainer; Tron, Christophe; Dumenteil, Nicolas; Linke, Axel; Ten Berg, Jurriën M; Deliargyris, Efthymios N; Anthopoulos, Prodromos; Mehran, Roxana; Dangas, George